Taking the cost out of R&D and researching again

Date of publication: February 6, 2006

Author: Bob Leitman


As consumer healthcare costs escalate, the pharmaceutical industry continues to lose consumer trust. Pharmaceutical companies can reduce consumers drug costs as a route to improving the industry's image by reducing prices and thereby profits; or reducing the cost structure with lesser out of pocket consumer costs. As pharmaceutical companies can/will not reduce costs and profits and continue heavy investment in R&D, only option two seems plausible.The research industry, especially the Interactive market research industry, can help reduce the cost of bringing drugs to market through more cost effective recruitment and obtaining potential enrollee feedback before trial designs are written in stone.

  • PDF
  • This could also be of interest